To analyze end-of-life (EOL) costs and cost trajectories across different age groups, with a particular emphasis on younger individuals with private insurance and their unique cost patterns.
Key Findings:
EOL costs represent a significant portion of Medicare expenditures, despite being incurred by a small percentage of beneficiaries.
Younger individuals with private insurance likely incur higher EOL costs due to higher reimbursement rates and more aggressive treatment, highlighting a critical area for policy focus.
The study provides insights into EOL costs across a full spectrum of ages, which has been previously under-researched, emphasizing the need for further investigation.
Interpretation:
The findings underscore the necessity for a deeper understanding of EOL costs among younger individuals with private insurance, as their cost patterns may differ significantly from those of older Medicare beneficiaries, suggesting a need for tailored health policy responses.
Limitations:
The study was exempt from institutional review board approval due to the use of deidentified data, which may limit the generalizability of the findings.
EOL costs were limited to those with identifiable claims, potentially excluding individuals with no health care costs, which could skew the understanding of overall EOL expenditures.
Conclusion:
This study sheds light on the patterns of health care expenditure in the final year of life across different age groups, emphasizing the need for targeted health policy initiatives that address the unique challenges faced by younger individuals with private insurance.
